Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

被引:158
作者
Licht, C.
Heinen, S.
Jozsi, M.
Loeschmann, I.
Saunders, R. E.
Perkins, S. J.
Waldherr, R.
Skerka, C.
Kirschfink, M.
Hoppe, B.
Zipfel, P. F.
机构
[1] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07743 Jena, Germany
[2] Univ Cologne, Childrens Hosp, Cologne, Germany
[3] UCL, Dept Biochem & Mol Biol, Royal Free & Univ Coll Med Sch, London, England
[4] Inst Clin Pathol, Heidelberg, Germany
[5] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany
[6] Univ Jena, Fac Biol, Jena, Germany
关键词
complement; hemolytic uremic syndrome; membranoproliferative glomerulonephritis (MPGN); Factor H; alternative complement pathway;
D O I
10.1038/sj.ki.5000269
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report a novel pathomechanism for membranoproliferative glomerulonephritis type II (MPGN II) caused by a mutant Factor H protein expressed in the plasma. Genetic analyses of two patients revealed deletion of a single Lys residue (K224) located within the complement regulatory region in domain 4 of Factor H. This deletion resulted in defective complement control: mutant protein purified from the plasma of patients showed severely reduced cofactor and decay-accelerating activity, as well as reduced binding to the central complement component C3b. However, cell-binding activity of the mutant protein was normal and comparable to wild-type Factor H. The patients are daughters of consanguineous parents. As both patients but also their healthy mother were positive for C3 nephritic factor, the mutant Factor H protein is considered relevant for unrestricted activation of the disease-causing activation of the alternative complement pathway. Replacement of functional Factor H by fresh frozen plasma (10-15 ml/kg/14 days) was well tolerated, prevented so far disease progression in both patients, and is in the long run expected to preserve kidney function.
引用
收藏
页码:42 / 50
页数:9
相关论文
共 48 条
[1]  
Atkinson JP, 2003, J CLIN INVEST, V112, P1639
[2]   Factor H and the pathogenesis of renal diseases [J].
Ault, BH .
PEDIATRIC NEPHROLOGY, 2000, 14 (10-11) :1045-1053
[3]   Human factor H deficiency - Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism [J].
Ault, BH ;
Schmidt, BZ ;
Fowler, NL ;
Kashtan, CE ;
Ahmed, AE ;
Vogt, BA ;
Colten, HR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25168-25175
[4]  
Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkp985, 10.1093/nar/gkr1065, 10.1093/nar/gkh121]
[5]   Adhesion mechanism of human β2-glycoprotein I to phospholipids based on its crystal structure [J].
Bouma, B ;
de Groot, PG ;
van den Elsen, JMH ;
Ravelli, RBG ;
Schouten, A ;
Simmelink, MJA ;
Derksen, RHWM ;
Kroon, J ;
Gros, P .
EMBO JOURNAL, 1999, 18 (19) :5166-5174
[6]   COMBINED HOMOZYGOUS FACTOR-H AND HETEROZYGOUS C2 DEFICIENCY IN AN ITALIAN FAMILY [J].
BRAI, M ;
MISIANO, G ;
MARINGHINI, S ;
CUTAJA, I ;
HAUPTMANN, G .
JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (01) :50-56
[7]  
Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297
[8]   Crystal structure of two CD46 domains reveals an extended measles virus-binding surface [J].
Casasnovas, JM ;
Larvie, M ;
Stehle, T .
EMBO JOURNAL, 1999, 18 (11) :2911-2922
[9]  
DAHA MR, 1976, J IMMUNOL, V116, P1
[10]  
DAVISON AM, 2005, OXFORD TXB CLIN NEPH